The background to the use of the present receptor blockade was a series of studies on receptor regulation in cerebral ischemia models which has revealed elevation of AT1, ETA and ETB receptors [19,20] and [32] in MCA smooth muscle cells. Here, EDNRA is linked to brain ischemia.